Is Ampio Pharmaceuticals, Inc. (AMPE) a Buy, Sell, or Hold?
OTC : AMPE
Ampio Pharmaceuticals, Inc.
$0.1831 USD
$0 (0.0%)
- Volume
- 334
- Average Volume
- 33
- Market Capitalization
- $207.88K
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.64
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.41
Company Overview
OTC
Michael A. Martino
Biotechnology
Healthcare
AMPE
6
US
USD
Liquidity Metrics
0.08
2.41
2.41
1.72
0.00
Sales & Valuation
-$
0.00
0.04
-0.02
-10.59
Profitability
-$10.66
-$8.63M
0.00%
0.00%
-113.96%
-150.49%
P/E Metrics
-0.02
0.00
0.00
Analyst Price Target & Rating
0/5
2 Analysts
%
Financial Health Scores
-63.76
3/9
$3.36M
$5.74M
$2.38M
-$9.33M
Key Metrics (TTM)
-$3.61M
0.00
0.43
2.41
-113.96%
-252.47%
-5827.40%
-4119.61%
-1095 days
Company Executives
| Name | Title |
|---|---|
| Michael A. Martino | Chief Executive Officer, Chief Financial Officer, General Secretary & Director |
| David Bar-Or | Founder & Chairman of Scientific Advisory Board |
| April Ramirez | Clinical Trial Manager |
Poll Results
No votes yet today — be the first to share your view!
About Ampio Pharmaceuticals, Inc. (OTC:AMPE) Stock
Ampio Pharmaceuticals, Inc., headquartered in Englewood, Colorado, is a biopharmaceutical firm dedicated to advancing immunomodulatory therapeutics primarily for the management of osteoarthritis pain across the United States. Their developmental pipeline currently features several compounds: AP-013, an intra-articular injection, is undergoing Phase III clinical trials for knee osteoarthritis. Additionally, the company has multiple candidates addressing COVID-19: AP-017, an intravenous Ampion formulation, is in Phase II for adult COVID-19 patients who require supplemental oxygen; AP-019, an inhaled Ampion treatment, also in Phase II, targets adults experiencing respiratory distress from COVID-19; while AP-018, currently in Phase I, aims to treat individuals with persistent respiratory sympt ... oms following COVID-19 infection.
Frequently Asked Questions
-
What is the current Ampio Pharmaceuticals, Inc. (AMPE) stock price?
-
Ampio Pharmaceuticals, Inc.(OTC:AMPE) stock price is $0.1831 in the last trading session. During the trading session, AMPE stock reached the peak price of $0.6435 while $0.0027 was the lowest point it dropped to. The percentage change in AMPE stock occurred in the recent session was 0.0% while the dollar amount for the price change in AMPE stock was $0.
-
AMPE's industry and sector of operation?
-
The OTC listed AMPE is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AMPE?
-
Michael A. Martino | Chief Executive Officer, Chief Financial Officer, General Secretary & Director
David Bar-Or | Founder & Chairman of Scientific Advisory Board
April Ramirez | Clinical Trial Manager
|
| -
How many employees does AMPE have?
-
Number of AMPE employees currently stands at 6. AMPE operates from 9800 Mount Pyramid Court, Englewood, CO 80112, US.
-
Link for AMPE official website?
-
Official Website of AMPE is: https://www.ampiopharma.com
-
How do I contact AMPE?
-
AMPE could be contacted at phone #720 437 6500 and can also be accessed through its website. AMPE operates from 9800 Mount Pyramid Court, Englewood, CO 80112, US.
-
How many shares of AMPE are traded daily?
-
The average number of AMPE shares traded daily for last 3 months was 33.
-
What is the market cap of AMPE currently?
-
The market value of AMPE currently stands at $207.88K with its latest stock price at $0.1831